These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15929170)
21. Insulin-like growth factor 1 promotes growth of gastric cancer by inhibiting foxo1 nuclear retention. Li S; Lei X; Zhang J; Yang H; Liu J; Xu C Tumour Biol; 2015 Jun; 36(6):4519-23. PubMed ID: 25596089 [TBL] [Abstract][Full Text] [Related]
22. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629 [TBL] [Abstract][Full Text] [Related]
23. Expression of gastrin and its receptor in human gastric cancer tissues. Hur K; Kwak MK; Lee HJ; Park DJ; Lee HK; Lee HS; Kim WH; Michaeli D; Yang HK J Cancer Res Clin Oncol; 2006 Feb; 132(2):85-91. PubMed ID: 16228228 [TBL] [Abstract][Full Text] [Related]
27. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes. Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329 [TBL] [Abstract][Full Text] [Related]
28. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062 [TBL] [Abstract][Full Text] [Related]
30. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872 [TBL] [Abstract][Full Text] [Related]
31. Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines. Jang JY; Kim SW; Ku JL; Park YH; Park JG World J Gastroenterol; 2005 Feb; 11(6):803-9. PubMed ID: 15682471 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161 [TBL] [Abstract][Full Text] [Related]
33. Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma. Smith JP; Shih AH; Wotring MG; McLaughlin PJ; Zagon IS Int J Oncol; 1998 Feb; 12(2):411-9. PubMed ID: 9458369 [TBL] [Abstract][Full Text] [Related]
34. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. Konturek PC; Kania J; Kukharsky V; Ocker S; Hahn EG; Konturek SJ J Physiol Pharmacol; 2003 Mar; 54(1):17-32. PubMed ID: 12674216 [TBL] [Abstract][Full Text] [Related]
35. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma. Ye P; Qu CF; Hu XL Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570 [TBL] [Abstract][Full Text] [Related]
36. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue. Chong KY; Subramanian A; Mokbel K; Sharma AK J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260 [TBL] [Abstract][Full Text] [Related]
37. Expression of albumin, IGF-1, IGFBP-3 in tumor tissues and adjacent non-tumor tissues of hepatocellular carcinoma patients with cirrhosis. Luo SM; Tan WM; Deng WX; Zhuang SM; Luo JW World J Gastroenterol; 2005 Jul; 11(27):4272-6. PubMed ID: 16015705 [TBL] [Abstract][Full Text] [Related]
38. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival. Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909 [TBL] [Abstract][Full Text] [Related]
39. A ligand-based and enediyne-energized bispecific fusion protein targeting epidermal growth factor receptor and insulin-like growth factor-1 receptor shows potent antitumor efficacy against esophageal cancer. Cao HY; Guo XF; Zhu XF; Li SS; Zhen YS Oncol Rep; 2017 Jun; 37(6):3329-3340. PubMed ID: 28498434 [TBL] [Abstract][Full Text] [Related]
40. Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer. Triantafillidis JK; Merikas E; Govosdis V; Konstandellou E; Cheracakis P; Barbatzas C; Tzourmakliotis D; Peros G Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclvi-cclx. PubMed ID: 15244195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]